Han Jun, Lin Karen, Sequeira Carita, Borchers Christoph H
University of Victoria - Genome BC Proteomics Centre, University of Victoria, Vancouver Island Technology Park, 3101-4464 Markham Street, Victoria, BC V8Z 7X8, Canada.
University of Victoria - Genome BC Proteomics Centre, University of Victoria, Vancouver Island Technology Park, 3101-4464 Markham Street, Victoria, BC V8Z 7X8, Canada; Department of Biochemistry and Microbiology, University of Victoria, Petch Building Room 207, 3800 Finnerty Road, Victoria, BC V8P 5C2, Canada.
Anal Chim Acta. 2015 Jan 7;854:86-94. doi: 10.1016/j.aca.2014.11.015. Epub 2014 Nov 15.
Short-chain fatty acids (SCFAs) are produced by anaerobic gut microbiota in the large bowel. Qualitative and quantitative measurements of SCFAs in the intestinal tract and the fecal samples are important to understand the complex interplay between diet, gut microbiota and host metabolism homeostasis. To develop a new LC-MS/MS method for sensitive and reliable analysis of SCFAs in human fecal samples, 3-nitrophenylhydrazine (3NPH) was employed for pre-analytical derivatization to convert ten C2-C6 SCFAs to their 3-nitrophenylhydrazones under a single set of optimized reaction conditions and without the need of reaction quenching. The derivatives showed excellent in-solution chemical stability. They were separated on a reversed-phase C18 column and quantitated by negative-ion electrospray ionization - multiple-reaction monitoring (MRM)/MS. To achieve accurate quantitation, the stable isotope-labeled versions of the derivatives were synthesized in a single reaction vessel from (13)C6-3NPH, and were used as internal standard to compensate for the matrix effects in ESI. Method validation showed on-column limits of detection and quantitation over the range from low to high femtomoles for the ten SCFAs, and the intra-day and inter-day precision for determination of nine of the ten SCFAs in human fecal samples was ≤8.8% (n=6). The quantitation accuracy ranged from 93.1% to 108.4% (CVs≤4.6%, n=6). This method was used to determine the SCFA concentrations and compositions in six human fecal samples. One of the six samples, which was collected from a clinically diagnosed type 2 diabetes patient showed a significantly high molar ratio of branch-chain SCFAs to straight-chain SCFAs than the others. In summary, this work provides a new LC-MS/MS method for precise and accurate quantitation of SCFAs in human feces.
短链脂肪酸(SCFAs)由大肠中的厌氧肠道微生物群产生。对肠道和粪便样本中的短链脂肪酸进行定性和定量测量,对于理解饮食、肠道微生物群和宿主代谢稳态之间的复杂相互作用至关重要。为了开发一种用于灵敏可靠地分析人类粪便样本中短链脂肪酸的新型液相色谱-串联质谱(LC-MS/MS)方法,采用3-硝基苯肼(3NPH)进行分析前衍生化,在一组优化的反应条件下,将十种C2-C6短链脂肪酸转化为它们的3-硝基苯腙,且无需反应淬灭。衍生物在溶液中表现出优异的化学稳定性。它们在反相C18柱上分离,并通过负离子电喷雾电离-多反应监测(MRM)/质谱进行定量。为实现准确定量,在单个反应容器中由(13)C6-3NPH合成衍生物的稳定同位素标记版本,并用作内标以补偿电喷雾电离中的基质效应。方法验证表明,十种短链脂肪酸的柱上检测限和定量限范围从低到高飞摩尔,并且在人类粪便样本中测定十种短链脂肪酸中的九种的日内和日间精密度≤8.8%(n=6)。定量准确度范围为93.1%至108.4%(变异系数≤4.6%,n=6)。该方法用于测定六份人类粪便样本中的短链脂肪酸浓度和组成。从一名临床诊断为2型糖尿病患者收集的六份样本中的一份,其支链短链脂肪酸与直链短链脂肪酸的摩尔比显著高于其他样本。总之,这项工作提供了一种用于精确和准确定量人类粪便中短链脂肪酸的新型LC-MS/MS方法。